Transcriptome profiles associated to VHSV infection or DNA vaccination in turbot (Scophthalmus maximus) by Pereiro, Patricia et al.
Transcriptome Profiles Associated to VHSV Infection or
DNA Vaccination in Turbot (Scophthalmus maximus)
Patricia Pereiro1, Sonia Dios1, Sebastia´n Boltan˜a2,5, Julio Coll3, Amparo Estepa4, Simon Mackenzie2,5,
Beatriz Novoa1*, Antonio Figueras1
1 Instituto de Investigaciones Marinas (IIM), CSIC, Vigo, Spain, 2 Institute of Aquaculture, University of Stirling, Stirling, Scotland, United Kingdom, 3Dpto Biotecnologı´a,
Instituto Nacional Investigaciones Agrarias (INIA), Madrid, Spain, 4 Instituto de Biologı´a Molecular y Celular (IBMC), Miguel Herna´ndez University, Elche, Spain, 5 Institut de
Biotecnologia i de Biomedicina, Universitat Auto`noma de Barcelona, Barcelona, Spain
Abstract
DNA vaccines encoding the viral G glycoprotein show the most successful protection capability against fish rhabdoviruses.
Nowadays, the molecular mechanisms underlying the protective response remain still poorly understood. With the aim of
shedding light on the protection conferred by the DNA vaccines based in the G glycoprotein of viral haemorrhagic
septicaemia virus (VHSV) in turbot (Scophthalmus maximus) we have used a specific microarray highly enriched in antiviral
sequences to carry out the transcriptomic study associated to VHSV DNA vaccination/infection. The differential gene
expression pattern in response to empty plasmid (pMCV1.4) and DNA vaccine (pMCV1.4-G860) intramuscular administration
with regard to non-stimulated turbot was analyzed in head kidney at 8, 24 and 72 hours post-vaccination. Moreover, the
effect of VHSV infection one month after immunization was also analyzed in vaccinated and non-vaccinated fish at the same
time points. Genes implicated in the Toll-like receptor signalling pathway, IFN inducible/regulatory proteins, numerous
sequences implicated in apoptosis and cytotoxic pathways, MHC class I antigens, as well as complement and coagulation
cascades among others were analyzed in the different experimental groups. Fish receiving the pMCV1.4-G860 vaccine
showed transcriptomic patterns very different to the ones observed in pMCV1.4-injected turbot after 72 h. On the other
hand, VHSV challenge in vaccinated and non-vaccinated turbot induced a highly different response at the transcriptome
level, indicating a very relevant role of the acquired immunity in vaccinated fish able to alter the typical innate immune
response profile observed in non-vaccinated individuals. This exhaustive transcriptome study will serve as a complete
overview for a better understanding of the crosstalk between the innate and adaptive immune response in fish after viral
infection/vaccination. Moreover, it provides interesting clues about molecules with a potential use as vaccine adjuvants,
antiviral treatments or markers for vaccine efficiency monitoring.
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Introduction
Viral haemorrhagic septicaemia virus (VHSV) is a fish pathogen
belonging to the genus Novirhabdovirus, within the family
Rhabdoviridae. This etiological agent causes an important viral
disease affecting rainbow trout Oncorhyncus mykiss and other
salmonids [1–3] but VHSV outbreaks have been detected in other
marine farmed fish species such as turbot (Scophthalmus maximus
L. 1758) [4], [5]. Nowadays, the culture of this flatfish is well-
established being a very important commercial species for the
aquaculture industry in Europe and Asia. However, infectious
diseases are one of the most relevant limiting factors, causing
severe economic losses in many cases. Neither vaccines nor
therapeutic treatments are commercially available for this disease.
Increased efforts were performed for more than 30 years in order
to produce an efficient, safe and cost-effective vaccine against
VHSV using subunits or single viral proteins as well as killed or
attenuated viruses [6–11]. Although some of those vaccines have
induced good protection levels in laboratory conditions, they can
either be unsafe for field use, its production very expensive or
require high doses. DNA vaccination is based on the administra-
tion of a plasmidic DNA vector containing the gene encoding a
specific antigen. This technology is a powerful tool for the design
of effective vaccines against fish rhabdoviral pathogens. Rhabdo-
viruses possess a surface glycoprotein G that acts as the target of
virus neutralizing antibodies [12] and therefore, the most
successful DNA vaccines against these viruses are based on the
G glycoprotein gene under the control of the cytomegalovirus
promoter (CMV). We have recently constructed a DNA vaccine
encoding the G glycoprotein from VHSV strain UK-860/94
(isolated from infected turbot) and have demonstrated the high
degree of protection provided against this virus as well as the
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production of specific neutralizing antibodies one month after
vaccination [13]. However, the early immune mechanisms
implicated in the success of that vaccination remain still unclear.
Microarray technology is a very useful tool for the understand-
ing of the immune process implicated in the protective response
provided by efficient DNA vaccines against fish rhabdoviral
infection. Some studies have been previously performed using
microarrays, including the effect of a DNA vaccine encoding the
infectious hematopoietic necrosis virus (IHNV) G glycoprotein in
trout [14], the effect of the expression of the G protein from
VHSV in Japanese flounder [15], [16], as well as the differences in
the gene expression profile following hirame rhabdovirus
(HIRRV) G and N protein DNA vaccination in Japanese flounder
[17] and the expression pattern after HIRRV challenge in
vaccinated and non-vaccinated fish [18]. However, the informa-
tion provided by these reports was, in some cases, limited due to
the relatively low number of annotated immune-related sequences
included in the microarray. To our knowledge, this is the first
global work in fish including both the analysis of the expression
profile after DNA vaccination and the analysis of the differential
transcriptomic patterns in vaccinated and non-vaccinated fish after
rhabdoviral infection and the first performed in turbot. Moreover,
the microarray has been constructed using a high number of
annotated sequences obtained from an enriched 454-pyrosequenc-
ing of turbot transcriptome after viral stimulations [19], providing
a higher quantity of information compared to previous similar
publications in other fish species. The gene expression patterns of
several immune-relevant pathways were analyzed and allowed a
better comprehension of the protective mechanisms underlying
VHSV G protein DNA vaccination before and after VHSV
challenge.
Materials and Methods
Ethical statement
Experimental procedures followed Spanish Law (Royal Exec-
utive Order, 53/2013) for Animal Experimentation, in accordance
with European Union directive 2010/63/UE. Fish care and
challenge experiments were reviewed and approved by the CSIC
National Committee on Bioethics (approval number:
07_09032012).
Fish
Juvenile turbot (average weight 2.5 g) were obtained from a
VHSV-free commercial fish farm (Insuin˜a S.L., Mouga´s, Galicia,
Spain). Animals were maintained in 500 L fibreglass tanks at the
IIM (CSIC) facilities with a re-circulating saline water system with
a light-dark cycle of 12:12 h at 18uC and fed daily with a
commercial diet (LARVIVA-BioMar). Prior to experiments, fish
were acclimatized to laboratory conditions for 2 weeks.
Plasmids
The expression vector pMCV1.4 (Ready-Vector, Madrid,
Spain) was used for the construction of the vaccine containing
the G glycoprotein cDNA sequence from VHSV strain UK-860/
04 (GeneBank accession number AY546628) as was previously
described by Pereiro et al. [13]. High amounts of DNA vaccine
(pMCV1.4-G860) and the corresponding empty plasmid
(pMCV1.4) were obtained by transformation in One Shot
Figure 1. Diagram reflecting the experimental design and sampling points employed in the study of the transcriptomic profiles
associated to the vaccination and VHSV infection. This experimental prodecure is explained in detail in the materials and methods section.
doi:10.1371/journal.pone.0104509.g001
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TOP10F’ chemically competent E. coli (Invitrogen) for its cloning
following the protocol instructions. Bacteria were cultured on LB-
Kanamycin (50 mg/ml) agar plates during 24 h at 37uC and an
isolated colony from each transformation was selected and
cultured in LB-Kanamycin (50 mg/ml) medium at 37uC in
agitation. Plasmid constructions were purified using the PureLink
HiPure Plasmid Midiprep Kit (Invitrogen) following the manu-
facturer’s instruction.
VHSV strain UK-860/94
Viral haemorrhagic septicaemia virus UK-860/94 (VHSV860)
isolated from farmed turbot in Scotland [5] was propagated in
Epithelioma papulosum cyprini (EPC) cells at 14uC containing
Eagle’s minimum essential medium (MEM, Gibco) supplemented
with 2% fetal bovine serum (FBS), penicillin (100 IU/ml)
(Invitrogen) and streptomycin (100 mg/ml) (Invitrogen). The
supernatants were clarified by centrifugation at 40006g during
30 min and viruses from these supernatants were concentrated by
ultracentrifugation at 100,0006g for 45 min. VHSV860 aliquots
were maintained at –80uC until use. Virus stock was titrated in 96-
well plates according to Reed & Mue¨nch [20] and the in vivo
infectivity was tested using juvenile turbot.
Immunization and viral infection protocols
A schematic overview of the vaccination/challenge protocol and
sampling procedure is shown in Fig. 1. A total number of 204
juvenile turbot were divided into 3 groups, two of them containing
72 fish and the last one 60 fish. Turbot were anaesthetized by
immersion in 50 mg/ml buffered tricaine methanesulfonate (MS-
222; Sigma) and then, fish from the first two groups were
intramuscularly (i.m.) injected with 50 ml of PBS containing 2 mg
of pMCV1.4 or pMCV1.4-G860. Turbot from the last batch were
i.m. inoculated with 50 ml of PBS. At 8, 24 and 72 h after
injection, 12 fish were removed from the first two tanks and, at 8 h
after PBS inoculation, other 12 fish were taken from the last tank.
These turbot were sacrificed by anaesthetic overdose and the head
kidney was removed. Equal amounts of tissue from three fish
belonging to the same tank and sampling point were pooled,
obtaining 4 biological replicates for each treatment and time point
(3 turbot/replicate). The remaining fish (36 in the plasmid-injected
groups and 48 in the PBS-inoculated tank) were maintained
during one month and then, 12 fish from the PBS injected group
were separated to another tank. This new group of fish was
intraperitoneally (i.p.) injected with 50 ml of MEM + penicillin and
streptomycin+2% FBS (PBS - MEM group), whereas the other
turbot were i.p. infected with a dose of VHSV860 of 5610
5
TCID50/fish (pMCV1.4 - VHSV and pMCV1.4-G860 - VHSV
groups). At 8, 24 and 72 hours after infection, 12 fish were
removed from the VHSV-infected tanks, and at 8 h after MEM
injection the 12 fish were taken from the non-infected tank. The
fish were sacrificed by anaesthetic overdose and the head kidney
was removed. Equal amounts of tissue from three fish belonging to
the same tank and sampling point were pooled, obtaining 4
biological replicates for treatment and time point (3 turbot/
replicate). The whole experimental procedure was conducted in
parallel to the previously published work in which the high
protective effect induced by the pMCV 1.4-G860 vaccine was
demonstrated, obtaining a relative percent survival (RPS) higher
than 80% [13]. Mortality events were not recorded in the absolute
control groups (non-immunized and non-infected fish) during the
experiment. The health status of the fish was daily monitored and
no adverse health effects were observed in non-infected turbot.
The animals used in this work were sacrificed before they
exhibited clinical signs of disease (8, 24 and 72 hours post-
infection).
Total RNA extraction, quality control and cDNA synthesis
RNA was extracted from 68 samples using TRIzol (Invitrogen)
in accordance with instructions provided by the manufacturer in
combination with the RNeasy mini kit (Qiagen) for RNA
purification after DNase treatment (RNase-free DNase set,
Qiagen). RNA concentration was quantified using the spectro-
photometer Nanodrop ND-1000 (Thermo Scientific). RNA
integrity and quality were also assessed (Bioanalyzer 2100, Agilent
Technologies). The RNA integrity number (RIN) was calculated
for each sample and only RNAs with a RIN number .7 were
processed. For qPCR validation of the microarray results, the
cDNA synthesis was performed with SuperScript II Reverse
Transcriptase (Invitrogen) using 0.5 mg of RNA by following the
manufacturer indications.
Oligonucleotide microarray design
A specific turbot microarray enriched in immune-related genes
was designed by selecting the sequences obtained after a 454-
pyrosequencing of several S. maximus tissues at different sampling
points after viral stimulation (VHSV strain UK-860/94 and
Nodavirus strain AH95-NorA) or using molecules mimicking viral
infection (pMCV1.4, pMCV1.4-G860 and Poly I:C) [19]. This tool
was used for analyzing the transcriptome profiles associated to the
VHSV infection or DNA vaccination in turbot, as well as the
differences between vaccinated and non-vaccinated fish after viral
infection. The five proteins encoded by the VHSV genome (RNA-
directed RNA polymerase L, Nucleoprotein, Phosphoprotein,
Spike glycoprotein and Matrix protein), whose sequences were
obtained in the pyrosequencing, were also included in the
microarray in order to analyze the evolution of the viral
replication in vaccinated and non-vaccinated fish.
A total of 43,398 oligonucleotide probes (60-mer long each)
were used to construct a high-density turbot microarray based on
the Agilent 4644K design format using the Agilent eArray
interface. Thus, 10,907 annotated contigs were spotted in
triplicated into the slide (total probes 32,721), as well as 4,654
spotted in duplicated (9,308). In addition, 18 selected singletons
with 2 replicated probes (total probes 36) were also spotted as well
as 1,417 internal control probes of Agilent (N = 43,398). The
microarray platform TurbotV2_SSFN (ID041183 Agilent) has
been submitted to the Gene Expression Omnibus (GEO)
repository under accession number GPL16776.
RNA Labeling and Microarray Hybridization
RNA labelling, hybridizations and scanning were performed
according to manufacturer’s instructions. Total RNA (500 ng) was
amplified and Cy3-labeled with Agilent’s One-Color Microarray-
Based Gene Expression Analysis (Quick Amp Labelling kit) along
with Agilent’s One-Color RNA SpikeIn Kit. Each amplified and
labelled sample was briefly hybridized at 65uC for 17 hours.
Microarray slides were scanned with Agilent Technologies
Scanner model G2505B. Spot intensities and other quality control
features were extracted with the Feature Extraction software
version 10.4.0.0 (Agilent). One-channel TIFF images were
imported into the GeneSpring GX 12.0 software (Agilent).
Microarray data analysis
Fluorescence intensity data and quality measurements were
analyzed using the GeneSpring GX 12.0 software (Agilent). After
grouping the biological replicates (4 replicates for treatment and
Transcriptome after VHSV Infection or Vaccination
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sampling point), data were filtered by flags and then by expression
between the 20 and 95th percentile in the raw data. Once the
analysis by probes was performed, the gene-level experiment was
conducted normalizing the data by percentile shifts at the 75th
percentile and using as baseline transformation the median of all
samples. In order to identify differentially expressed genes, the
normalized data were analyzed by filtering on Volcano Plot in
order to compare the mean expression levels between treatments
(pMCV1.4 and pMCV1.4-G860 treatments against PBS [8 h] -
control group- and PBS - VHSV, pMCV1.4 - VHSV and
pMCV1.4-G860 - VHSV treatments against PBS - MEM [8 h] -
control group-). An unpaired t-test was conducted without
correction and data were considered significant at p,0.05. The
fold-change cut-off was set at 1.5. The data presented in this
publication and the MIAME-compliant information has been
deposited in the NCBI’s Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and is available under the
accession number GSE56487.
The five viral proteins encoded by VHSV were excluded for
subsequent analysis of the turbot transcriptomic profiles. Venn
diagrams representing the number of shared and exclusive
modulated genes among different experimental conditions were
also constructed by using GeneSpring GX 12.0 software. This
bioinformatic tool was also chosen for performing hierarchical
clustering using Euclidean distance metric of several groups of
selected genes. Blast2GO suite [21] was used for Gene Ontology
(GO) classification into biological process terms of the significantly
modulated genes from each comparison.
qPCR validation
The expression profiles of five immune-related genes modulated
in the microarray (Tumor necrosis factor, Interferon phi 2,
Interferon-induced GTP-binding protein Mx, IFI56 and Interfer-
on-stimulated gene 15) were determined at 3 different times from
vaccinated and non-vaccinated fish by using reverse transcriptase
real-time quantitative qPCR. Specific PCR primers were designed
using the Primer3 program [22] and their amplification efficiency
was calculated using seven serial five-fold dilutions of head kidney
cDNA from unstimulated turbot with the Threshold Cycle (CT)
slope method [23]. Primer sequences are listed in the Table S1.
Individual reactions were carried out in 25 ml reaction volume
using 12.5 ml of SYBR GREEN PCR Master Mix (Applied
Biosystems), 10.5 ml of ultrapure water (Sigma-Aldrich), 0.5 ml of
each specific primer (10 mM) and 1 ml of five-fold diluted cDNA
template in MicroAmp optical 96-well reaction plates (Applied
Biosystems). All reactions were performed using technical tripli-
cates in a 7300 Real-Time PCR System thermocycler (Applied
Biosystems) with an initial denaturation (95uC, 10 min) followed
by 40 cycles of a denaturation step (95uC, 15 s) and one
hybridization-elongation step (60uC, 1 min). An analysis of
melting curves was performed for each reaction. Relative
expression of each gene was normalized using the Elongation
Factor-1 alpha as reference gene, which was constitutively
expressed and not affected by the experimental treatments, and
calculated using the Pfaffl method [23]. The correlation between
microarray and qPCR data (Log10 fold-change) were analyzed by
the Spearman’s Rho test.
Figure 2. qPCR validation of the microarray data. Correlation between microarray (x-axis) and qPCR (y-axis) data (Log10 fold-change) from 5
genes at 3 different times after infection of vaccinated and unvaccinated turbots. Fold-change values of the selected genes were displayed in Table
S1. The correlation between microarray and qPCR data analyzed by the Spearman’s Rho test was r= 0.969 and with a statistical significance of p,
0.01.
doi:10.1371/journal.pone.0104509.g002
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Results and Discussion
Validation of microarray data by qPCR
Quantitative real-time PCR (qPCR) is a commonly used
validation tool for confirming gene expression results obtained
from microarray analysis [24]. In order to validate the expression
profiles from microarray analysis, the relative mRNA level for 5
immune-relevant genes (Tumor necrosis factor, Interferon phi 2,
Interferon-induced GTP-binding protein Mx, IFI56 and Interfer-
on-stimulated gene 15) was measured by qPCR. The expression
data obtained by microarray and qPCR for the selected genes are
listed in the Table S2 and plotted in Fig. 2. Microarray and qPCR
results were analyzed by Spearmans Rho test and a high
correlation (r= 0.969) and a statistical significance (p,0.01) were
observed.
Transcription of viral genes in non-vaccinated and
vaccinated turbot infected with VHSV
In order to assess the viral replication success of VHSV strain
UK-860/94 in head kidney cells from vaccinated and non-
vaccinated fish infected with VHSV, the expression of the five viral
genes was analyzed. The evolution of the VHSV replication
throughout the tested sampling points (8, 24 and 72 hours after
infection) in the different experimental groups is shown in Fig. 3.
Those fish that were previously inoculated intramuscularly with
PBS or with the empty plasmid (pMCV1.4) and one month later
infected with VHSV showed an increasing viral replication from 8
hours to 72 hours post-challenge, being the five proteins already
detected at 8 hours. On the other hand, turbot previously injected
with the DNA vaccine encoding the G glycoprotein (pMCV1.4-
G860) showed a limited quantity of viral transcripts after VHSV
challenge. Thus, matrix protein and RNA-directed RNA poly-
merase L were not significantly increased in vaccinated fish at any
of the tested time points, whereas the other three genes were only
detected after 72 hours post-infection and in a lower level in
comparison with the other two groups of non-vaccinated fish. This
reduction in the number of viral transcripts in the host cells and, as
consequence, the high survival rates obtained after vaccination,
might be directly related to the presence of specific neutralizing
antibodies against VHSV (strain UK-860/94) one month after
immunization as was previously reported [13]. However, we
cannot rule out that some non-specific immune responses could
also be contributing to the reduction of viral replication because it
is known that the specific protection provided by VHSV and
IHNV G gene DNA vaccines in fish is preceded by a protective
nonspecific antiviral response, possibly related to interferon-
induced mechanisms [25]. In fact, interestingly, turbot previously
receiving only the empty plasmid and then challenged with VHSV
one month later showed a significantly reduced expression of all
VHSV genes when compared to the PBS-injected VHSV-
challenged group. This reduction in the transcription of viral
genes could be related to the persistence of a non-specific immune
response probably due to the induction of several immune factors
by unmethylated CpG motifs present in the plasmid backbone
[26–28]. DNA vaccines are constructed from plasmids of bacterial
DNA that are able to induce the maturation, differentiation and
proliferation of the immune cells and, therefore, to increase the
production of the several cytokines [29]. Ritter et al. [30] revealed
that immunization using the empty plasmids pcDNA3 and pORF
was able to reduce the number of colony-forming units (CFU) of
the bacteria Paracoccidioides brasiliensis in mice. Other publica-
tion showed some but modest protective effect against Mycobac-
terium tuberculosis in mice after vaccination with the empty
plasmid pGX10 [31]. With regard to fish viruses, a protective
response against the Infectious Pancreatic Necrosis Virus (IPNV)
in Atlantic salmon was also observed one week after CpG
oligodeoxynucleotides stimulation, revealing the induction of a
nonspecific immune response against virus [32]. Indeed, some
experiments have shown that the early immune response induced
shortly after DNA vaccination against VHSV in trout is non-
specific and cross-protective against other rhabdoviruses [33], [34]
and even against nodavirus in turbot [35]. Although in our turbot
vaccination trials we did not observe any significant difference in
final mortalities between PBS and empty plasmid-injected fish
groups, only a slight reduction and delay in the mortality [13], our
results suggest the importance of the intrinsic adjuvant properties
of the plasmids used in DNA vaccination [28] and the persistence
of the non-specific immune response.
Overall effect of pMCV1.4-G860 immunization on the host
gene expression
Total quantity and fold-changes of up and down-regulated
genes in head kidney after pMCV1.4 or pMCV1.4-G860
intramuscular injections are shown as stacked column charts in
Fig. 4. The number of modulated genes increased with time when
compared to the control group (PBS-injected fish) in both cases. In
agreement with the reduction of the viral genes expression, the
empty plasmid was able to induce the modulation of several genes
and this induction increased from 8 to 72 h. Differences in the
number of modulated genes between pMCV1.4 and pMCV1.4-
G860 were highest at 72 h, when the transcription of the G
glycoprotein gene is on-going as was previously observed [13].
Intramuscular administration of microgram amounts of DNA
vaccine is enough for the expression of the viral G glycoprotein on
the surface of muscular cells and this is the way to trigger the
orchestration of an adaptive immune response [25], [36]. A total
of 1,495 genes were found to be regulated at 72 h after vaccination
(630 up-regulated and 865 down-regulated), whereas the empty
plasmid induced the expression of 382 genes at the same time
point (140 up-regulated and 242 down-regulated).
A Gene Ontology (GO) classification of biological processes at
the 2nd level of the modulated genes after plasmids injection is
provided in Fig. S1. Those GO categories containing a high
representation of genes with a direct implication in immunity
(Viral reproduction, Signaling, Response to stimulus, Death, Cell
proliferation and Immune system process) showed, in general,
their highest representations at 24 h when the empty plasmid was
administrated and at 72 h after pMCV1.4-G860 vaccination.
Venn diagrams representing exclusive and common genes after
pMCV1.4 or pMCV1.4-G860 injection are provided in Fig. S2.
The number of exclusive genes at 72 h after vaccination was 580
for the up-regulated sequences and 799 for the down-regulated
sequences, whereas the empty plasmid administration induced the
up-regulation of 90 exclusive genes and the down-regulation of
176 at 72 h. In order to identify those GO categories especially
affected during the expression of the G glycoprotein, biological
process multilevel pie charts of exclusive and common regulated
sequences at 72 h after DNA vaccine or pMCV1.4 empty plasmid
Figure 3. Evolution of viral genes transcription in non-vaccinated and vaccinated turbot. Sequences for the five proteins encoded by
VHSV were included in the microarray design for analyzing their evolution in non-vaccinated (PBS – VHSV and pMCV1.4– VHSV) and vaccinated
(pMCV1.4-G860– VHSV) individuals at 8, 24 and 72 h post-challenge.
doi:10.1371/journal.pone.0104509.g003
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injection were constructed and are displayed in Fig. S3. Several
immune-related GO terms were found to be highly represented
among the pMCV1.4-G860 exclusive genes, such as I-kappaB
kinase/NF-kappaB cascade, activation of immune response,
antigen processing and presentation, cytokine production, immune
effector process, innate immune response and regulation of
apoptosis, among others. Proteolysis was found to be the category
including the highest number of exclusive sequences both in the
group of up and down-regulated genes (29 and 34 genes,
respectively), which is a GO term containing several molecules
implicated in the antigen processing and presentation. On the
other hand, empty plasmid exclusive genes as well as common
genes between both groups did not show a remarkable represen-
tation of these terms at the tested time point.
Figure 4. Stacked column chart reflecting the distribution of regulated genes through time after pMCV1.4 or pMCV1.4-G860
intramuscular injection. Statistically significant differential gene expressions are subdivided according to intensity (fold change) and sense (up and
down-regulation).
doi:10.1371/journal.pone.0104509.g004
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Differential gene expression profile in vaccinated and
non-vaccinated turbot after VHSV challenge
Stacked column charts reflecting the number and intensity of up
and down-modulated genes in non-vaccinated and vaccinated fish
after VHSV challenge is represented in Fig. 5. The pattern of
regulated genes induced by VHSV challenge is quite different
from that observed after viral infection in vaccinated fish. The
viral challenge induced a time-increasing modulation in the global
gene expression, whereas vaccinated fish showed the highest
number of up and down-regulated genes at 24 h. Moreover, the
number of genes appearing significantly modulated in vaccinated
individuals at 24 and 72 h after VHSV infection is quite lower in
comparison with the other treatments. Another remarkable point
is the difference observed between both non-vaccinated groups
(PBS – VHSV and pMCV1.4– VHSV), where the fish previously
receiving the empty plasmid showed a higher number of
modulated genes at 8 h, suggesting once again a persistence of
innate immune factors one month after empty plasmid injection.
A GO classification of biological processes at the 2nd level (Fig.
S4) revealed a very higher number of those sequences with direct
implication in immune defense in the pMCV1.4– VHSV group at
8 h compared to the PBS – VHSV fish. Unlike the other two
treatments, where the number of immune genes increased from 8
to 72 h, vaccinated individuals showed the peak of maximum
expression of these sequences at 24 h and a relevant reduction at
72 h. But, interestingly, as it was illustrated in the Venn diagrams
(Fig. S5) vaccinated fish presented the major number of exclusive
modulated genes at 72 h. Therefore, although the number of
regulated sequences decreased at 72 h and the total number of up
and down-regulated genes was lower in vaccinated fish with regard
to the other groups, this exclusivity could be associated with genes
directly related with the existence of adaptive immunity.
Hierarchical clustering analysis of pathways or groups of
molecules involved in defense mechanisms
In order to effectively combat viral infections and other diseases,
vertebrate organisms have developed an efficient, powerful and
integrated defense network comprising both innate and adaptive
immune mechanisms. Numerous defensive processes or families of
molecules implicated in non-specific or specific responses against
VHSV were analyzed using hierarchical clustering in order to
define the transcriptomic profiles after pMCV1.4-G860 vaccination
as well as after VHSV infection in vaccinated and non-vaccinated
turbot. Sequences directly related with the TLR pathway, IFN
system, apoptosis, MHC-I antigen presentation, and coagulation
among others were shown to be involved in the viral infection and
also in the protection provided by the vaccine.
TLR pathway. Virus detection by the innate immune system
is carried out by a class of molecules known as pattern recognition
receptors (PRRs), which detect specific evolutionary conserved
structures on pathogens, termed pathogen-associated molecular
patterns (PAMPs) [37]. Toll-like receptors (TLRs), a class of PRRs,
have been established to play a crucial role in the innate immune
response to pathogens through the activation of intracellular
signalling pathways, which ultimately induce expression of a large
number of genes encoding type I interferons (IFNs), inflammatory
cytokines and chemokines, and other molecules affecting the
initiation of adaptive immune responses [38].
Six different TLRs were found to be modulated by some
treatment in the microarray analysis (TLR2, TLR3, TLR5,
TLR6, TLR8 and TLR13) as well as numerous molecules directly
implicated in the signalling cascade downstream of the TLR-
PAMP interaction. The immune response mediated by these
PRRs implies the activation of the transcription factors NF-kappa-
B, IRF3 and IRF7 [39], [40]. IRF3 and IRF7 are the main factors
responsible in the induction of antiviral innate immunity by
inducing the expression of type I IFN genes [41]. The expression
level of these genes in the different experimental groups was
represented as a heat map (Fig. 6).
DNA vaccine administration significantly up-regulated the
expression of TLR8, a PRR directly implicated in the recognition
of viral nucleic acids, with a fold-change (FC) of 3.5 with regard to
the PBS control group at 72 h post-immunization. IRF3 and IRF7
were also affected by the vaccine at the same time point (FC = 15
and FC = 3.6, respectively). Moreover, some genes related with the
activity of the transcription factor NF-kappa-B, such as the
activator IKKbeta or the NF-kappa-B inhibitor zeta, were
significantly down-regulated by pMCV1.4-G860. TLR2 recognize
other viral components such as envelope glycoproteins [42] and,
although no significant up-regulations were observed for this gene
after vaccination, the heat map reflects a slight induction. TLR2
activation induces apoptosis through a FADD/Caspase 8 pathway
[43] and both genes appeared overrepresented at 72 h, revealing a
possible stimulation of the TLR pathway via TLR2 and
ultimately, inducing apoptosis.
With regard to the viral challenge (PBS – VHSV and
pMCV1.4– VHSV groups), it is interesting to highlight that some
Toll-like receptors with a typical role in bacterial component
detection (TLR5 and TLR6) have been found to be strongly
regulated after VHSV infection, and this induction could suggest a
novel role of these receptors in the recognition of viral
components. A sequence annotated as TLR13 was also modulated
at 24 h; there is little information about the function of this
receptor and the nature of their ligands remains still poorly
understood, but there are evidences about the recognition of
bacterial rRNA [44] as well as vesicular stomatitis virus [45] by
TLR13. As was expected, the typical viral-recognition receptors
TLR3 and TLR8 were significantly up-regulated after VHSV
challenge. Focusing the attention in the downstream signalling
components, a pronounced induction of several proteins was
observed (MyD88, IRF3, IRF7, FADD, Caspase-8, etc). Some
molecules were also found to be down-regulated, including
inhibitors of the transcription factor NF-kappa-B as well as
numerous molecules implicated in their activation, possibly due to
the maintenance of equilibrium in the NF-kappa-B activity.
On the other hand, VHSV infection in vaccinated fish
(pMCV1.4-G860– VHSV) revealed a completely different pattern,
even TLR2 and TLR5 were found to be significantly down-
regulated at 24 h and the other TLRs were not affected by the
viral infection. As a consequence, the induction of downstream
proteins was practically suppressed or down-regulated and only in
the case of IRF3 and IRF7 significant up-regulations were
detected at 24 h, with a return to the basal levels at 72 h.
The IFN system. The interferon (IFN) system is an early
antiviral immune process controlling most virus infections in the
absence of specific immunity, buying time for the generation of
adaptive defense mechanisms [46]. Nowadays is well known that
Figure 5. Stacked column chart reflecting the distribution of regulated genes through time after VHSV challenge in non-vaccinated
(PBS – VHSV or pMCV1.4– VHSV) and vaccinated (pMCV1.4-G860– VHSV) turbot. Statistically significant differential gene expressions are
subdivided according to intensity (fold change) and sense (up and down-regulation).
doi:10.1371/journal.pone.0104509.g005
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fish type I IFNs induce the expression of a wide variety of IFN-
stimulated genes (ISGs) after recognition of specific IFN receptors
[47]. These ISGs reduce the viral replication and dissemination
through different blocking mechanisms. Two type I IFNs,
annotated as ‘‘Interferon phi 2’’ and ‘‘Interferon alpha 2
precursor’’, as well as some of the most relevant IFN-related
sequences modulated in the microarray were analyzed in the
different groups (Fig. 7). Recently these two turbot type I IFNs
were characterized and renamed as Ifn1 and Ifn2, respectively
[48].
No up-regulations were detected in the level of any of both IFNs
after vaccination, and even Interferon alpha 2 precursor (renamed
as Ifn2) was significantly down-regulated in comparison with
control fish (FC =24.3). However, Interferon regulatory factors
(IRFs 1, 3, 4, 7 and 8) and the majority of ISGs were up-regulated
after 72 h. The most induced ISG by pMCV1.4-G860 was Mx
(FC = 66), followed by Interferon-inducible protein 56 (FC = 44.4)
and IFI56 (FC = 39.3), two genes or different parts of the same
gene belonging to the IFIT (IFN-induced protein with TPR
repeats) family [49]. These up-regulations in downstream genes
revealed an activation of the IFN signalling pathway after
Figure 6. Heat map displaying hierarchical clustering results from microarray expression data of genes implicated in the Toll-like
receptor signalling pathway. All the experimental groups, including the corresponding controls (PBS 8 h and PBS – MEM 8 h), were included in
the analysis. Different genes are represented in different rows, and different experiments in different columns. Raw expression values are represented
as a color scale from red for lower expressions to green for higher expressions.
doi:10.1371/journal.pone.0104509.g006
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immunization with pMCV1.4-G860 even when no up-regulations
in the expression of IFNs were observed.
After viral infection a remarkable induction of these genes was
observed with some exception. Thus, Interferon phi 2 (Ifn1) was
highly up-regulated especially at 72 h (FC = 593.3 and FC = 177.7
in fish injected with PBS - VHSV and pMCV1.4 - VHSV,
respectively), whereas Interferon alpha 2 precursor (Ifn2) tran-
scription was down-regulated. Interestingly, we previously ob-
served that both turbot IFNs were overexpressed after VHSV
challenge although at different level, being Ifn1 strongly induced
and Ifn2 slightly up-regulated and with a brief induction time [48].
Nevertheless, an overall and strong up-regulation of ISGs was
observed. There are evidences suggesting that different forms of
type I IFNs may have complementary antiviral activities in
different cells, at different stages of infection or differ functionally
[47], and this was also observed for turbot type I IFNs. Whereas
Ifn1 (‘‘Interferon phi 2’’) showed a typical antiviral activity (ISGs
induction and protection against VHSV infection), Ifn2 was no
able to increase the expression of ISGs and therefore, did not show
any protective effect against VHSV, but was able to up-regulate
the level of several immune-related genes, including pro-inflam-
matory cytokines [48].
Figure 7. Heat map displaying hierarchical clustering results from microarray expression data of genes involved in the IFN system
(IFNs, IRFs, ISGs…). All the experimental groups, including the corresponding controls (PBS 8 h and PBS – MEM 8 h), were included in the analysis.
Different genes are represented in different rows, and different experiments in different columns. Raw expression values are represented as a color
scale from red for lower expressions to green for higher expressions.
doi:10.1371/journal.pone.0104509.g007
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When vaccinated fish were infected (pMCV1.4-G860– VHSV),
a weaker up-regulation of some IFN-related genes was observed at
24 h in comparison with both non-vaccinated groups. This
modulation diminished at 72 h, nearly returning to basal levels.
In fact, the high expression of Interferon phi 2 (Ifn1) after VHSV
challenge was not significantly affected in pMCV1.4-G860
vaccinated turbot after infection at any of the sampling points.
Therefore, vaccinated turbot showed a limited IFN-response after
viral challenge.
Apoptosis. One of the most important mechanisms prevent-
ing viral replication and dissemination is the apoptosis or
programmed cell death, in which infected cells are eradicated
through the activation of a group of proenzymes known as
caspases [50]. The heat map containing several of the most
relevant proteins implicated in apoptosis (Fig. 8A) revealed the
induction of multitude of pro-apoptotic genes following
pMCV1.4-G860 vaccination, including the initiator caspases
Caspase-8 and Caspase-10 and the effector caspases Caspase-6
and Caspase-7, as well as Caspase-1 or Caspase-1A. The injection
of the empty plasmid pMCV1.4 was also capable of inducing up-
regulation of some genes especially implicated in the apoptotic
intrinsic pathway (Diablo homolog mitochondrial, BCL2/adeno-
virus E1B 19 kDa protein-interacting protein 3, Calpain-2
catalytic subunit, DNA-damage-inducible transcript 4-like protein,
Apoptosis regulator BAX, Cytochrome c).
VHSV infection (PBS – VHSV and pMCV1.4– VHSV groups)
revealed an extensive induction of genes implicated in apoptosis.
Thus, all the caspases contained in the microarray were
significantly and strongly up-regulated, indicating a powerful
activation of the programmed cell death. The profile reflecting the
apoptotic induction after viral challenge in pMCV1.4-G860
vaccinated turbot was totally different. Thus, the existence of a
specific immune response seems to reduce the viral transcription to
a level that practically avoids the activation of the apoptotic
mechanisms. Indeed, the caspases analyzed in the microarray were
not affected in pMCV1.4-G860 vaccinated fish after VHSV
challenge at any of the sampling points. Significant but slight
up-regulation in the expression of some specific apoptosis genes
was only detected at 24 h (Apoptosis regulator BAX, Apoptosis
regulator BAX membrane isoform alpha, Apoptosis-associated
speck-like protein containing a CARD).
On the other hand, cytotoxic T lymphocytes (CTLs) and
natural killer (NK) cells are also able to induce cell death through
the Perforin/Granzyme-induced apoptosis, in which Perforin and
Granulysin (or NK-lysin) generate membrane disruption of virally
infected cells and a family of structurally related serine proteases
(Granzymes) induces apoptosis of the target cell activating the
caspases [51]. As it is shown in Fig. 8B, at 72 h after pMCV1.4-
G860 injection the levels of Granzyme A (FC = 7.6), Perforin-1
(FC = 3.1) and Antimicrobial peptide NK-lysin (FC = 1.8) were
significantly up-regulated, indicating the activation of the cytotoxic
cells after viral G glycoprotein expression. As expected, these genes
mediating the cytotoxic response were also overexpressed after
VHSV administration but, once again, the pattern was very
different in previously vaccinated fish (pMCV1.4-G860– VHSV),
where this effect was practically voided.
Activated cytotoxic cells induce apoptosis in virally infected cells
after the recognition of MHC-I-presented peptides as foreign [52].
Moreover, cross-presentation of antigens derived from apoptotic
infected cells by professional antigen presenting cells, such as
dendritic cells, is another important way for initiating CD8
cytotoxic lymphocyte responses to virus [53]. Therefore, a direct
correlation between apoptosis induction and overexpression of
antigen presentation molecules could be established.
MHC class I antigen presentation. Protein ubiquitination
is a mechanism that serves as a mark for the degradation of self
and foreign proteins, such as viral molecules. The process of
ubiquitination allows the recognition of proteins by the 26S
proteasome, a complex that degrades ubiquitinated proteins to
small peptides [54]. These peptides could be finally presented as
antigens on the plasma membrane, throughout the Major
Histocompatibility Complex class I (MHC-I) assembly and peptide
binding process [55]. The expression pattern of several ubiquitin-
related genes was analyzed for determining the effect of
pMCV1.4-G860 vaccination as well as the response to VHSV
infection (Fig. 9A). At 72 h after pMCV1.4-G860 vaccine injection,
several genes corresponding to ubiquitin-protein ligases were up-
regulated, as well as some ubiquitin-conjugating enzymes. Slight
down-regulations were also observed in other ubiquitin-related
genes. The viral challenge induced the expression of a broad range
of these genes, but strong inhibitions of some genes were also
detected and, therefore, more investigations will be necessary in
order to determine the role of the different ubiquitin-related
proteins in the viral antigen presentation process. On the other
hand, VHSV infection of vaccinated turbot showed only a
moderate induction at 24 h of some of the genes up-regulated in
non-vaccinated fish and, interestingly, some ubiquitin-ligases up-
regulated in both groups of non-vaccinated fish were significantly
down-regulated in vaccinated individuals, especially E3 ubiquitin-
protein ligase NEURL3 and Protein neuralized. The opposite
response of these genes in non-immunized and immunized turbot
after VHSV infection is an interesting point for further investiga-
tions.
Regarding the genes encoding the different subunits of the
proteasome complex (Fig. 9B), the injection of pMCV1.4-G860
induced the transcription of multitude of them. More evident was
the up-regulation of all the analyzed genes after viral challenge in
both groups of non-vaccinated individuals, whereas vaccinated fish
showed only a modest up-regulation of some of these subunits at
24 h after VHSV challenge.
As a consequence of the activation of ubiquitin and proteasome-
related genes, it was expected that pMCV1.4-G860 administration
and VHSV infection would have induced the up-regulation of the
main genes implicated in the MHC-I antigen presentation
(Fig. 9C). pMCV1.4-G860 vaccination and VHSV infection up-
regulated the expression of MHC-I and related genes, although
some down-regulations were also observed in genes implicated also
in other biological functions (e.g. Platelet glycoprotein 4). On the
other hand, turbot previously vaccinated with pMCV1.4-G860
presented only a modest induction of some of the above
mentioned genes after viral challenge probably as consequence
of the existence of an adaptive immune response limiting the
proliferation success of the virus.
Coagulation, platelet-related proteins and complement
cascade. The complement system and coagulation are two
closely related pathways belonging to a complex inflammatory
Figure 8. Heat map displaying hierarchical clustering results from microarray expression data of genes involved in the (A)
apoptosis pathway and in the (B) cell death induced by cytotoxic cells. All the experimental groups, including the corresponding controls
(PBS 8 h and PBS – MEM 8 h), were included in the analysis. Different genes are represented in different rows, and different experiments in different
columns. Raw expression values are represented as a color scale from red for lower expressions to green for higher expressions.
doi:10.1371/journal.pone.0104509.g008
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network and showing an intense interaction between them [56].
Pro-inflammatory cytokines play a central role in the coagulation
and fibrinolysis pathways and, in an inverse way, the activation of
the coagulation system may affect the inflammatory responses
[57].
Some coagulation-related genes were significantly modulated at
3 days after pMCV1.4-G860 vaccine administration (Fig. 10A).
Thus, the most up-regulated genes were Heparanase, Tetranectin-
like protein, Platelet basic protein, Vitamin K-dependent protein S
and Myelin-associated protein. On the other hand, significant
down-regulations were detected for example in Alpha-actinin-2,
Figure 9. Heat map displaying hierarchical clustering results from microarray expression data of genes involved in the MHC-I
antigen presentation process. (A) Enzymes involved in the ubiquitination of target proteins. (B) Subunits belonging to the proteasome complex.
(C) MHC class I related-proteins and molecules implicated in the antigen-MHC class I assembly. All the experimental groups, including the
corresponding controls (PBS 8 h and PBS – MEM 8 h), were included in the analysis. Different genes are represented in different rows, and different
experiments in different columns. Raw expression values are represented as a color scale from red for lower expressions to green for higher
expressions.
doi:10.1371/journal.pone.0104509.g009
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Thrombospondin-1, Thombospondin-2, EGF-containing fibulin-
like extracellular matrix protein 2 and von Willebrand factor
among others. Both coagulant and anticoagulant genes were up
and down-regulated after pMCV1.4-G860 vaccine injection and,
therefore, it is difficult to establish a general pattern with regard to
this process.
After VHSV infection an intense regulation of these genes was
also observed. Thus, some anticoagulatory and procoagulatory
genes were tightly up-regulated but others were down-regulated.
Viral Haemorrhagic Septicaemia (VHS) is a viral disease causing
widespread haemorrhages (bleeding) in fish tissues, including
internal organs. It is well known that tissue injury induces an
inflammatory response and the systemic inflammation is a potent
prothombotic stimulus, up-regulating procoagulant factors, down-
regulating natural anticoagulants and inhibiting fibrinolytic
activity [58]. Although the role of inflammation is to resolve
infection and injury, excessive or altered inflammation often leads
to a wide range of tissue injuries and diseases, such as multi-organ
failure [59]. Therefore, the equilibrium between pro-inflammatory
and anti-inflammatory molecules is essential for the host survival.
This could be the explanation for the alternative modulation of
these coagulation-related proteins during VHSV infection. As
occurs with the previously analyzed groups of immune-related
proteins, the VHSV infection of pMCV1.4-G860 vaccinated turbot
showed a more moderate modulation of these genes. The presence
of specific immunity would lead to a decrease of tissue injury and
inflammation through the reduction of the number of viral
particles in the fish.
As mentioned above, the complement system is a cascade
closely related with the coagulation, with numerous interactions
between both pathways. Indeed, thrombin acts as a potent C3 and
C5 convertase, leading the generation of the anaphylotoxins C3a
and C5a [56]. The central component of the complement system
is the component C3, which is proteolytically activated through
the classical, lectins and alternative routes [60], as well as by the
coagulation system. As it is observed in Fig. 10B, the administra-
tion of the plasmid (both pMCV1.4 and pMCV1.4-G860) up-
regulated some complement components, especially at 24 h (for
instance, Complement component C8 gamma, CD59 glycopro-
tein, Mannan-binding lectin serine protease 2, Complement
component C9, Complement C2, Complement factor B and
Complement C4). In contrast, Complement receptor type 1, C3a
anaphylatoxin chemotactic receptor and C5a anaphylatoxin
chemotactic receptor were down-regulated 24 h after any plasmid
injection. Therefore, the plasmid DNA backbone was able to
induce an immune response at the complement level. The
modulation in the expression of these genes could be related to
the differences observed between both groups of non-vaccinated
fish after viral challenge (higher number of affected genes at 8 h
post-infection, lower transcription of viral genes and reduction and
delay in the mortality of fish previously injected with pMCV1.4).
In addition, pMCV1.4-G860 vaccination up-regulated the expres-
sion of Complement C4 and Complement C4-A, and down-
regulated the level of C5a anaphylatoxin chemotactic receptor at
72 h.
On the other hand, VHSV challenge increased the expression
of the majority of the analyzed genes but, interestingly, a
significant reduction in the transcription of Complement C1q
subcomponent subunit C was observed. However, this transcript
appeared slightly up-regulated in pMCV1.4-G860– VHSV turbot
at 8, 24 and 72 h after infection. C1 complex is part of the classical
pathway of the complement, which implicates the participation of
antibodies. The presence of specific antibodies against VHSV in
pMCV1.4-G860 vaccinated fish could be affecting the expression
of Complement C1q subcomponent subunit C and therefore,
favouring the classical pathway of the complement system.
Markers of activation and proliferation of immune-
relevant cell types. The last hierarchical analysis was con-
ducted for determining the modulation of genes implicated in the
maturation, proliferation or activation of different cell lineages.
Some membrane markers and two sequences with homology to
macrophage colony-stimulating factors were selected and their
pattern of relative expression obtained (Fig. 11). Three days after
vaccination down-regulations were observed for the gene corre-
sponding to the CD81 protein (FC =23.6) and the Macrophage
mannose receptor 1 (FC =22.5). CD81 is a tetraspanin cell
surface protein showing a broad expression on numerous immune
cells and it is known to play an important role in multiple cellular
interactions [61]. Chang et al. [62] found that interferon-alpha
treatment is able to suppress the CD81 expression, possibly
through the activity of the double-stranded RNA activated kinase;
our results revealed a significant up-regulation of this ISG after
pMCV1.4-G860 vaccination in turbot. The other down-regulated
gene, Macrophage mannose receptor 1, is a cell surface
transmembrane glycoprotein expressed on macrophages that
serves as a phagocytic receptor mediating the binding and
ingestion microorganisms with a mannose-rich surface [63].
Harris et al. [64] observed that IFN-c administration decreased-
to-absent the cell-surface mannose receptor transcription in
murine macrophages. There are not sequences homologues to
IFN-c in the turbot microarray and therefore, a negative
correlation between the two proteins cannot be established.
However, Purcell et al. [14] found a high up-regulation of IFN-
c in rainbow trout in the site of injection (muscle) 7 days after
vaccination against the IHNV rhabdovirus after injecting a DNA
vaccine encoding its G glycoprotein. CD209 antigen-like protein
E, CD83 and CD9 were significantly up-regulated after vaccina-
tion. These three clusters of differentiation were also induced in
rainbow trout one week after injection of a similar DNA vaccine
from IHNV [14]. CD209 antigen-like protein E and CD83 are
mainly expressed in dendritic cells and these up-regulations could
be indicating a proliferation and activation of this cell type, which
forms a system of professional antigen-presenting cells.
VHSV infection especially induced the up-regulation of the
gene encoding the CD83 protein, indicating a possible activation/
proliferation of dendritic cells. Interestingly, this dendritic cells
marker was also found to be induced on monocytes [65] and
polymorphonuclear neutrophils [66] under the influence of
specific cytokines, such as TNF-a, acquiring characteristics of
dendritic cells. Slight up-regulations were also observed for the
CD166 antigen homolog, CD9 as well as for CD8 alpha chain and
CD8 beta, reflecting a putative activation of CD8+ T lymphocytes
(cytotoxic cells). However, weak down-regulations were also
obtained for several T-cell receptor (TCR) chain regions (fold-
changes between 21.5 and 22 in both non-vaccinated groups). B-
cell receptor complex-associated protein alpha chain and B-cell
Figure 10. Heat map displaying hierarchical clustering results from microarray expression data of genes belonging to the (A)
coagulation or (B) complement cascades. All the experimental groups, including the corresponding controls (PBS 8 h and PBS – MEM 8 h), were
included in the analysis. Different genes are represented in different rows, and different experiments in different columns. Raw expression values are
represented as a color scale from red for lower expressions to green for higher expressions.
doi:10.1371/journal.pone.0104509.g010
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receptor complex-associated protein beta chain (BCR chains) were
also down-modulated with a fold-change around 22. But the
more surprising down-regulations were observed for some
molecules with an exclusive/closely relation with macrophages.
Thus, the Macrophage receptor MARCO and the Macrophage
mannose receptor 1, two phagocyte receptor molecules serving as
a pattern-recognition receptor for bacterial components, were
highly down-modulated by VHSV administration especially after
72 h. In PBS - VHSV fish, MARCO showed a FC =246 and
Macrophage mannose receptor 1 a FC =210.2, whereas in
pMCV 1.4 - VHSV turbot showed FC =210.2 and 25.7,
respectively. Taking this information into consideration, together
with the strong down-regulation of Macrophage colony-stimulat-
ing factor 1 and Precursor of second macrophage colony-
stimulating factor, a reduction in the macrophage proliferation
or differentiation could be happening. An alternative explanation
would be a massive infection and destruction of these cells by the
virus. It has been shown that VHSV is able to infect turbot blood
leukocytes and kidney macrophages [67]. However, further
investigations have reported that macrophages are heterogeneous
in their permissiveness for viral penetration and usually only a
subpopulation is infected [67–70]. Therefore, the drastic effect
induced by VHSV in the expression of macrophage-related
proteins is still poorly understood and more studies need to be
performed for understanding if VHSV massively replicates in this
cell type. It is also interesting to highlight that Interleukin-18 (IL-
18) was down-regulated 72 h after VHSV challenge. IL-18 is a
potent pro-inflammatory cytokine essential to host defenses against
Figure 11. Heat map displaying hierarchical clustering results from microarray expression data of gene markers of activation and
proliferation of cell types. All the experimental groups, including the corresponding controls (PBS 8 h and PBS – MEM 8 h), were included in the
analysis. Different genes are represented in different rows, and different experiments in different columns. Raw expression values are represented as a
color scale from red for lower expressions to green for higher expressions.
doi:10.1371/journal.pone.0104509.g011
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severe infections, taking part in the clearance of viruses [71].
Macrophages are the main IL-18 producers in response to stimuli
of viral/bacterial origin [72] and the reduction in the mRNA level
of this cytokine after VHSV challenge was probably related with
the inhibition of the macrophage markers described above.
Little changes in the expression of the selected proteins were
observed in vaccinated turbot after infection, but a slight tendency
toward TCR sequences up-regulation was observed. Purcell et al.
[14] also suggested an enhanced T cell activation or proliferation
serving as mechanism of protection in Japanese flounder
immunized using a DNA vaccine encoding the HIRRV G gene
when fish were infected with the virus.
Conclusions
In summary, we have analyzed the importance of different
immune processes implicated in the protection provided by
pMCV1.4-G860 in turbot before and after VHSV infection. This
work represents the most exhaustive transcriptomic study about
DNA vaccines against rhabdoviral pathogens in fish. The high-
throughput screening provided will serve as a basis for a better
understanding of the molecular processes implicated in the
successful vaccination protocols against viral diseases in fish. The
plasmid pMCV1.4-G860 induces a powerful immune response at 3
days after vaccination affecting the main immune processes and
leading to an efficient antigen presentation and production of
specific antibodies. After VHSV challenge, non-vaccinated fish
revealed an uncontrolled immune response generating an intense
pro-inflammatory status in the host. In contrast, vaccinated fish
showed a moderate and controlled response due to the previous
presence of specific immune factors. The analyses performed in
this work provide interesting information about molecules with a
potential use as vaccine adjuvants, antiviral treatments or markers
for vaccine efficiency monitoring as well. Moreover, some clues
about the infectivity mechanisms of VHSV in fish are also
proposed.
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